Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Weighted gene co-expression network analysis and prognostic analysis identifies hub genes and the molecular mechanism related to head and neck squamous cell carcinoma.

Li Q, Chen W, Song M, Chen W, Yang Z, Yang A.

Cancer Biol Ther. 2019 Mar 22:1-10. doi: 10.1080/15384047.2018.1564560. [Epub ahead of print]


Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.

Guo YZ, Sun HH, Wang XT, Wang MT.

J Zhejiang Univ Sci B. 2018 Sept.;19(9):674-688. doi: 10.1631/jzus.B1700319.


The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites.

Günther K, Foraita R, Friemel J, Günther F, Bullerdiek J, Nimzyk R, Markowski DN, Behrens T, Ahrens W.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):197-205. doi: 10.1158/1055-9965.EPI-16-0492. Epub 2016 Oct 14.


Let-7c inhibits migration and epithelial-mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2.

Hou B, Ishinaga H, Midorikawa K, Nakamura S, Hiraku Y, Oikawa S, Ma N, Takeuchi K, Murata M.

Oncotarget. 2018 Jan 2;9(10):8927-8940. doi: 10.18632/oncotarget.23826. eCollection 2018 Feb 6.


Hypermethylated CD36 gene affected the progression of lung cancer.

Sun Q, Zhang W, Wang L, Guo F, Song D, Zhang Q, Zhang D, Fan Y, Wang J.

Gene. 2018 Dec 15;678:395-406. doi: 10.1016/j.gene.2018.06.101. Epub 2018 Jun 30.


Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.

Wu Y, Diao P, Li Z, Zhang W, Wang D, Wang Y, Cheng J.

J Oral Pathol Med. 2018 May;47(5):502-510. doi: 10.1111/jop.12708. Epub 2018 Apr 6.


Weighted gene co-expression network analysis reveals modules and hub genes associated with the development of breast cancer.

Qiu J, Du Z, Wang Y, Zhou Y, Zhang Y, Xie Y, Lv Q.

Medicine (Baltimore). 2019 Feb;98(6):e14345. doi: 10.1097/MD.0000000000014345.


MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.

Chiang KC, Yeh CN, Hsu JT, Chen LW, Kuo SF, Sun CC, Huang CC, Pang JH, Flanagan JN, Takano M, Kittaka A, Juang HH, Yang SW, Chen TC.

J Steroid Biochem Mol Biol. 2013 Nov;138:427-34. doi: 10.1016/j.jsbmb.2013.09.002. Epub 2013 Sep 14.


MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.

Liu F, Zhao X, Qian Y, Zhang J, Zhang Y, Yin R.

Biomed Pharmacother. 2017 Dec;96:229-237. doi: 10.1016/j.biopha.2017.08.145. Epub 2017 Oct 6.


Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.

Li P, Bian XY, Chen Q, Yao XF, Wang XD, Zhang WC, Tao YJ, Jin R, Zhang L.

PLoS One. 2017 May 11;12(5):e0177484. doi: 10.1371/journal.pone.0177484. eCollection 2017.


CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.

Yu B, Zhang Y, Wu K, Wang L, Jiang Y, Chen W, Yan M.

J Cell Mol Med. 2019 Feb;23(2):954-966. doi: 10.1111/jcmm.13996. Epub 2018 Nov 12.


Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.

Zhang L, Li Z, Liu Y, Xu S, Tandon M, Appelboom B, LaValle CR, Chiosea SI, Wang L, Sen M, Lui VWY, Grandis JR, Wang QJ.

BMC Cancer. 2018 Nov 12;18(1):1107. doi: 10.1186/s12885-018-4965-6.


HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.

Zhang H, Tang Z, Deng C, He Y, Wu F, Liu O, Hu C.

Oral Dis. 2017 Mar;23(2):255-264. doi: 10.1111/odi.12608. Epub 2016 Dec 23.


SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.

Barzegar M, Ma S, Zhang C, Chen X, Gu Y, Shang C, Jiang X, Yang J, Nathan CA, Yang S, Huang S.

Br J Cancer. 2017 Oct 10;117(8):1154-1163. doi: 10.1038/bjc.2017.298. Epub 2017 Sep 5.


HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.

Liu R, Zhang L, Yang J, Zhang X, Mikkelsen R, Song S, Zhou H.

PLoS One. 2015 May 1;10(5):e0125928. doi: 10.1371/journal.pone.0125928. eCollection 2015.


Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.

Bayo P, Jou A, Stenzinger A, Shao C, Gross M, Jensen A, Grabe N, Mende CH, Rados PV, Debus J, Weichert W, Plinkert PK, Lichter P, Freier K, Hess J.

Mol Oncol. 2015 Oct;9(8):1704-19. doi: 10.1016/j.molonc.2015.05.006. Epub 2015 May 20.


Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis.

Yamazaki H, Mori T, Yazawa M, Maeshima AM, Matsumoto F, Yoshimoto S, Ota Y, Kaneko A, Tsuda H, Kanai Y.

Lab Invest. 2013 Dec;93(12):1331-8. doi: 10.1038/labinvest.2013.120. Epub 2013 Oct 21.


Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.

Yun M, Choi AJ, Lee YC, Kong M, Sung JY, Kim SS, Eun YG.

J Exp Clin Cancer Res. 2018 Oct 30;37(1):264. doi: 10.1186/s13046-018-0942-9.


ANG Promotes Proliferation and Invasion of the Cell of Lung Squamous Carcinoma by Directly Up-Regulating HMGA2.

Xu L, Liao WL, Lu QJ, Li CG, Yuan Y, Xu ZY, Huang SD, Chen HZ.

J Cancer. 2016 Apr 28;7(7):862-71. doi: 10.7150/jca.14440. eCollection 2016.


Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.

Cao W, Feng Z, Cui Z, Zhang C, Sun Z, Mao L, Chen W.

Cancer. 2012 Jun 1;118(11):2858-71. doi: 10.1002/cncr.26575. Epub 2011 Oct 11.

Supplemental Content

Support Center